Article Information
PubMed
Print ISSN
Online ISSN
History
- Received March 29, 2021
- Accepted September 28, 2021
- Published online November 19, 2021.
Article Versions
- Earlier version (October 1, 2021 - 08:11).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2021 by The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Jennifer Tang,
- Hong Shen,
- Xiaofeng Zhao,
- Vinay K. Holenarsipur,
- T. Thanga Mariappan,
- Yueping Zhang,
- Erika Panfen,
- Jim Zheng,
- W. Griffith Humphreys, and
- Yurong Lai
- Drug Metabolism, Gilead Science Inc., Foster City, California (J.T., X.Z., J.Z., Y.L.); Drug Metabolism and Pharmacokinetics Department, Bristol-Myers Squibb Company, Princeton, New Jersey (H.S., Y.Z., E.P., W.G.H.); and Pharmaceutical Candidate Optimization, Biocon Bristol-Myers Squibb R&D Centre (BBRC), Syngene International Ltd., Bangalore, India (V.K.H., T.T.M.)
- Address correspondence to:
Dr. Hong Shen, Drug Metabolism and Pharmacokinetics Department, Bristol-Myers Squibb Company, Route 206 & Province Line Road, Princeton, NJ 08543. E-mail: hong.shen1{at}bms.com; or Dr. Yurong Lai, Gilead Sciences Inc. 333 Lakeside Dr. Foster City, CA 94404. E-mail: Yurong.Lai{at}gilead.com